Literature DB >> 14666727

Tumor-associated macrophages: foe or accomplice of tumors?

Satoshi Ohno1, Nobutaka Suzuki, Yumiko Ohno, Hiroyuki Inagawa, Gen-Ichiro Soma, Masaki Inoue.   

Abstract

Macrophages are predominantly involved in the immune and inflammatory processes of solid tumors. Macrophages infiltrated into a tumor have an ambivalent relationship with the tumor, because they are innately very flexible and adaptable depending on the microenvironment of the tissue and the tissue-derived factors. The relationship between tumor-associated macrophages (TAMs) and a tumor is extremely complicated and has not yet been clearly elucidated. Now, the reintegration of biological knowledge including immunology, pathology and oncology is indispensable for the clinical application of TAMs to cancer therapy. In this review, we focus on the range of pro- and anti-tumor functions performed by TAMs and outline a new class of cancer therapies that aims at controlling the complex functions of TAMs.

Entities:  

Mesh:

Year:  2003        PMID: 14666727

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.

Authors:  Sadamu Homma; Hideo Komita; Yukiko Sagawa; Tsuneya Ohno; Gotaro Toda
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

2.  Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs.

Authors:  Parag P Patwardhan; Oliver Surriga; Michael J Beckman; Elisa de Stanchina; Ronald P Dematteo; William D Tap; Gary K Schwartz
Journal:  Clin Cancer Res       Date:  2014-04-09       Impact factor: 12.531

3.  Cyclooxygenase-2 expression in the hereditary mixed polyposis syndrome.

Authors:  Eli Brazowski; Faina Misonzhnick-Bedny; Paul Rozen
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

Review 4.  Uterine myxoid leiomyosarcoma - a rare malignant tumor: the role of complex morphopathological assay. Review and case presentation.

Authors:  Anca Maria Istrate-Ofiţeru; George Lucian Zorilă; Dan Ruican; Ana Maria Petrescu; Elena Iuliana Anamaria Berbecaru; Gabriela Camelia Roşu; Răzvan Grigoraş Căpitănescu; Rodica Daniela Nagy; Liliana Cercelaru; Antonie Edu; Dominic Gabriel Iliescu; Roxana Cristina Drăguşin
Journal:  Rom J Morphol Embryol       Date:  2021 Oct-Dec       Impact factor: 0.833

5.  Carcinoembryonic antigen-stimulated THP-1 macrophages activate endothelial cells and increase cell-cell adhesion of colorectal cancer cells.

Authors:  Cary B Aarons; Olga Bajenova; Charles Andrews; Stanley Heydrick; Kristen N Bushell; Karen L Reed; Peter Thomas; James M Becker; Arthur F Stucchi
Journal:  Clin Exp Metastasis       Date:  2007-05-09       Impact factor: 5.150

6.  Perinecrotic hypoxia contributes to ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases.

Authors:  Jarmila D W van der Bilt; Marije E Soeters; Annique M M J Duyverman; Maarten W Nijkamp; Petronella O Witteveen; Paul J van Diest; Onno Kranenburg; Inne H M Borel Rinkes
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

7.  Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma.

Authors:  Kah-Whye Peng; Ahmet Dogan; Julie Vrana; Chunsheng Liu; Hooi T Ong; Shaji Kumar; Angela Dispenzieri; Allan B Dietz; Stephen J Russell
Journal:  Am J Hematol       Date:  2009-07       Impact factor: 10.047

8.  Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice.

Authors:  Eulalia de la Torre; Lilia Davel; María A Jasnis; Tomomi Gotoh; Eugenia Sacerdote de Lustig; María E Sales
Journal:  Breast Cancer Res       Date:  2005-03-04       Impact factor: 6.466

9.  Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression.

Authors:  Mabel Ryder; Matti Gild; Tobias M Hohl; Eric Pamer; Jeff Knauf; Ronald Ghossein; Johanna A Joyce; James A Fagin
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

10.  Stimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinoma.

Authors:  John-Helge Heimdal; Kenneth Kross; Beate Klementsen; Jan Olofsson; Hans Jørgen Aarstad
Journal:  BMC Cancer       Date:  2008-01-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.